Role of Multidisciplinary Management in mCRPC
Importance of Bone Health Agents in mCRPC Management
Combination of Radium-223 With Other Novel Agents in mCRPC
Radium 223: Counseling Patients With mCRPC
Management of mCRPC: Radium-223
Approaching Therapy for mCRPC
Therapeutic Options for mCRPC
Standard of Care for mCRPC
Case Overview: 69-Year-Old Man With Advanced CRPC
A 69-Year-Old Man With Advanced Castrate-Resistant Prostate Cancer
Jorge Garcia, MD, FACP, provides insight on the case of a 69-year-old man with mCRPC and assesses the classes of agents currently available as treatment options.